Ira Braunschweig, MD

Articles by Ira Braunschweig, MD

Dr. Braunschweig on Mitigating the Toxicities of CAR T-Cell Therapy in Lymphoma

ByIra Braunschweig, MD

November 5th 2020

Ira Braunschweig, MD, discusses mitigating the toxicities that are associated with CAR T-cell therapy in lymphoma.

Ira Braunschweig, MD, of Montefiore Medical Center

Dr. Braunschweig on Selecting Between Transplant and CAR T-Cell Therapy in DLBCL

ByIra Braunschweig, MD

November 4th 2020

Ira Braunschweig, MD, discusses factors to consider when selecting between autologous stem cell transplant, allogeneic stem cell transplant, and CAR T-cell therapy in diffuse large B-cell lymphoma.

Latest Updated Articles

Dr. Braunschweig on Mitigating the Toxicities of CAR T-Cell Therapy in Lymphoma
November 5th 2020
Dr. Braunschweig on Selecting Between Transplant and CAR T-Cell Therapy in DLBCL
November 4th 2020

Ira Braunschweig, MD

Articles by Ira Braunschweig, MD

Dr. Braunschweig on Mitigating the Toxicities of CAR T-Cell Therapy in Lymphoma

Dr. Braunschweig on Selecting Between Transplant and CAR T-Cell Therapy in DLBCL

Latest Updated Articles

Trending on OncLive

FDA Approval of Dostarlimab Brings Potential Organ-Sparing Approach in dMMR Locally Advanced Rectal Cancer

Treatment Tailoring and Weighing Alternative Formulations Support Optimal TKI Deployment in CML

Casdatifan Demonstrates Activity in Advanced Clear Cell RCC

HER2+ Maintenance Therapy Approvals and Innovative Brain Metastasis Care Reshape Breast Cancer Management

Lisaftoclax Plus Acalabrutinib Received Breakthrough Therapy Designation in China for Treatment-Naive CLL/SLL